NCT05844865 Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
| NCT ID | NCT05844865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Irvine |
| Condition | Peritoneal Carcinomatosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-05-04 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-05-04 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permission to provide blood and ascites/peritoneal wash fluid, tumor samples during their planned surgical procedure.
Eligibility Criteria
Inclusion Criteria: * Patients must have a GI tumor * Must have planned standard of care surgical procedure * Age ≥ 18 years. * Ability to understand and the willingness to sign a written informed consent Exclusion Criteria: \- Pattens who are unable to comply with the study protocol
Contact & Investigator
Chao Family Comprehensive Cancer Center University of California, Irvine
✉ ucstudy@uci.edu📞 1-877-827-7883
Maheswari Senthil, MD FACS
PRINCIPAL INVESTIGATOR
Chao Family Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT05844865 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Peritoneal Carcinomatosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05844865 currently recruiting?
Yes, NCT05844865 is actively recruiting participants. Contact the research team at ucstudy@uci.edu for enrollment information.
Where is the NCT05844865 trial being conducted?
This trial is being conducted at Orange, United States.
Who is sponsoring the NCT05844865 clinical trial?
NCT05844865 is sponsored by University of California, Irvine. The principal investigator is Maheswari Senthil, MD FACS at Chao Family Comprehensive Cancer Center. The trial plans to enroll 20 participants.